General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The 2016 spinal machined bone allograft market comprises anterior, posterior, transforminal and cervical interbody fusions. Anterior lumbar interbody fusion represented the largest segment. Closely following was CIF, PLIF and TLIF. The proportion of the machined bone allograft market by treatment will remain similar over the forecast period; the greatest change will be for the CIF segment, which will become the largest in the market by 2023.
All segments of this market will decline, experiencing both dropping unit sales and average selling prices. The PLIF and ALIF segments will be hit the hardest. Even though the number of spinal fusions performed in the United States is growing, this growth is associated with increased PEEK usage rather than machined bone allograft.
'
TABLE OF CONTENTS I
LIST OF FIGURES XVIII
LIST OF CHARTS XX
EXECUTIVE SUMMARY 1
U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE NUMBERS 9
MARKETS INCLUDED 11
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.1.1 Osteology and Musculoskeletal System 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 General Diagnostic 28
2.2.2 Osteoporosis 29
2.2.3 Osteoarthritis 29
2.2.4 Indication for Bone Graft Procedure 30
2.2.5 Indication for Cartilage Repair 31
2.2.6 Degenerative Disc Disease 32
2.3 PATIENT DEMOGRAPHICS 34
2.3.1 General Statistics 34
PRODUCT ASSESSMENT 36
3.1 PRODUCT PORTFOLIOS 36
3.1.1 Spinal Machined Bone Allografts 37
3.2 REGULATORY ISSUES AND RECALLS 40
3.2.1 Spinal Machined Bone Allografts 40
3.3 CLINICAL TRIALS 41
3.3.1 Spinal Machined Bone Allografts 41
SPINAL MACHINED BONE ALLOGRAFT MARKET 47
4.1 INTRODUCTION 47
4.1.1 Anterior Lumbar Interbody Fusion (ALIF) 48
4.1.2 Posterior Lumbar Interbody Fusion (PLIF) 48
4.1.3 Transforaminal Lumbar Interbody Fusion (TLIF) 48
4.1.3.1 Lateral Lumbar Interbody Fusion (LLIF) 48
4.1.3.2 Cervical Interbody Fusion (CIF) 49
4.1.4 Machined Bone Material 49
4.2 MARKET OVERVIEW 50
4.3 MARKET ANALYSIS AND FORECAST 53
4.3.1 Total Spinal Machined Bone Allograft Market 53
4.3.1.1 ALIF Machined Bone Allograft Market 55
4.3.1.2 PLIF Machined Bone Allograft Market 57
4.3.1.3 TLIF Machined Bone Allograft Market 59
4.3.1.4 CIF Machined Bone Allograft Market 61
4.4 DRIVERS AND LIMITERS 63
4.4.1 Market Drivers 63
4.4.2 Market Limiters 64
4.5 COMPETITIVE MARKET SHARE ANALYSIS 67
ABBREVIATIONS 71
APPENDIX II: COMPANY PRESS RELEASES 73
Chart 1 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023 3
Chart 4 1: Spinal Machined Bone Allograft Market by Segment, U.S., 2013 – 2023 51
Chart 4 2: Spinal Machined Bone Allograft Market Breakdown, U.S., 2016 52
Chart 4 3: Spinal Machined Bone Allograft Market Breakdown, U.S., 2023 52
Chart 4 4: Total Spinal Machined Bone Allograft Market, U.S., 2013 – 2023 54
Chart 4 5: ALIF Machined Bone Allograft Market, U.S., 2013 – 2023 56
Chart 4 6: PLIF Machined Bone Allograft Market, U.S., 2013 – 2023 58
Chart 4 7: TLIF Machined Bone Allograft Market, U.S., 2013 – 2023 60
Chart 4 8: CIF Machined Bone Allograft Market, U.S., 2013 – 2023 62
Chart 4 9: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2016 70
MedtronicGenzymeDePuy SynthesAnika TherapeuticsFerring PharmaceuticalsStrykerNuVasiveBioventusZimmer BiometIntegra LifeSciencesRTI SurgicalFidia PharmaceuticalsMTFOrthofixArthrexAlloSourceAastromBaxterHarvest TechnologiesWright MedicalBacterin InternationalArteriocyteExactechLifeNet HealthBiocompositesAlphatec SpineCelling BiosciencesGlobus MedicalNuo TherapeuticsK2M*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.